(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYTOVIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYTOVIVE

ST13

US500000087863269

Class

35, 42, 44

Filing

87863269

Registration

5719672

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

03/21/2025

Trademark type

Word

Nice classes

35, 42, 44

Filing date

04/04/2018

Registration date

04/09/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2025

Last transaction

03/21/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

03/23/2018

First use in commerce

03/23/2018

Drawing code

4

Owner type

16

Owner location

Tarpon Springs, FL

Examiner

SMITH, CYNTHIA

Current location

Historical data usage

Holders and representatives

Holders

CytoVive, LLC

Representatives

CytoVive, LLC

Technical classification

Nice Classes

Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences

Class 42

Technology research in the field of regenerative medicine

Class 44

Medical testing for diagnostic or treatment purposes

Publications

History of USPTO decisions and trademark events.

20 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/20/2025

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/20/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/20/2025

ES8R

TEAS SECTION 8 RECEIVED

08/04/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/22/2019

PUBO

PUBLISHED FOR OPPOSITION

01/22/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/02/2019

ALIE

ASSIGNED TO LIE

12/17/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/28/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/27/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/26/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/26/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/25/2018

GNRT

NON-FINAL ACTION E-MAILED

07/25/2018

CNRT

NON-FINAL ACTION WRITTEN

07/25/2018

DOCK

ASSIGNED TO EXAMINER

07/23/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/12/2018

NWAP

NEW APPLICATION ENTERED

04/07/2018

Continuous trademark protection

Get notified about every new filing that threatens CYTOVIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.